Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-12 06:06 am Unchanged | 2024-02-12 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA | Rubric Capital Management LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-01-25 1:48 pm Unchanged | 2024-01-25 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA | BlackRock Inc. BLK | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-08-18 4:32 pm Unchanged | 2023-08-18 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA | HILLHOUSE CAPITAL ADVISORS LTD. | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-08-10 4:15 pm Unchanged | 2023-08-10 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA | Fairmount Funds Management LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-03-08 2:15 pm Unchanged | 2023-03-08 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA | BlackRock Inc. BLK | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-14 4:08 pm Unchanged | 2023-02-14 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA | HILLHOUSE CAPITAL ADVISORS LTD. | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-09 11:25 am Unchanged | 2023-02-09 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA | The Vanguard Group | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-03 11:51 am Unchanged | 2023-02-03 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA | PICTET ASSET MANAGEMENT SA | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-01 4:54 pm Unchanged | 2023-02-01 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA | BlackRock Inc. BLK | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-09-08 1:43 pm Unchanged | 2022-09-08 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA | BlackRock Inc. BLK | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-14 10:56 am Unchanged | 2022-02-14 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA | AMERIPRISE FINANCIAL INC AMP | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-10 11:07 am Unchanged | 2022-02-10 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA | PICTET ASSET MANAGEMENT SA | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-10 08:22 am Unchanged | 2022-02-10 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA | The Vanguard Group | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-01-27 5:13 pm Unchanged | 2022-01-27 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA | BlackRock Inc. BLK | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-01-26 09:16 am Unchanged | 2022-01-26 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA | BlackRock Inc. BLK | 0 0.000% | 0 (Unchanged) | Filing |
| 2021-11-24 3:40 pm Unchanged | 2021-11-24 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA | BlackRock Inc. BLK | 0 0.000% | 0 (Unchanged) | Filing |
| 2021-11-10 09:43 am Unchanged | 2021-11-10 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA | BlackRock Inc. BLK | 0 0.000% | 0 (Unchanged) | Filing |